Skip to main content
Top
Published in: BMC Pediatrics 1/2019

Open Access 01-12-2019 | Gonadal Dysgenesis | Research article

Growth data and tumour risk of 32 Chinese children and adolescents with 45,X/46,XY mosaicism

Authors: Lili Pan, Zhe Su, Jianming Song, Wanhua Xu, Xia Liu, Longjiang Zhang, Shoulin Li, on behalf of the multidisciplinary collaboration team of DSD management at Shenzhen Children’s Hospital

Published in: BMC Pediatrics | Issue 1/2019

Login to get access

Abstract

Background

The aim of this study was to review the growth data, gonadal function and tumour risk of children and adolescents with 45,X/46,XY mosaicism who presented to a single centre in China.

Methods

We conducted a retrospective review of the records of 32 patients with 45,X/46,XY mosaicism or variants who were hospitalized from August 2005 to September 2018. The main outcomes measured were growth data, genital phenotype, gonadal function, gonadal position, and histological results.

Results

A total of 32 patients were included. The age at diagnosis ranged from 0.6 to 16.3 years. Nineteen patients exhibited ambiguous genitalia, 12 had short stature, and 1 showed a lack of breast development. Seventeen patients were raised as males, and 15 were raised as females. The external masculinisation score (EMS) of patients raised as male was 4.5 (1~12) [median (range)]. The EMS of the females was 0 (0~1.5) [median (range)]. Patients showed normal heights under 2 years old, with a height SDS of 0 (− 1.5~1.4) [median (range)]. Growth appeared to decelerate after age 2 years, with SDS decreased to − 2.8 (− 3.0~ − 0.9) [median (range)]. The percentage of short stature was higher in females than in males (76.9% vs 50.0%). Twenty-five patients had gonadal pathological results. Complete gonadal dysgenesis (CGD) and mixed gonadal dysgenesis (MGD) were the most common pathogenic subtypes, accounting for 48.0 and 36.0%, respectively. Ovotesticular tissue was observed in only 4.0% of patients. Gonadoblastoma and positive OCT3/4 results were found in 18.8% of gonads in children over 2 years of age. Palpable gonads accounted for 50% of these. All patients who had gonadoblastoma were raised as females.

Conclusions

Patients with 45,X/46,XY might have normal heights until 2 years old.
Growth decelerations after 2 years of age were common. Patients who are being raised as females seemed to be shorter than males. CGD and MGD were the most common gonadal pathogenic subtypes. The tumour risk is high in these patients, even in palpable gonads and female patients.
Literature
1.
go back to reference Hughes IA, Houk C, Ahmed SF, et al. Consensus statement on management of intersex disorders. J Pediatr Urol. 2006 Jun;2(3):148–62.PubMedCrossRef Hughes IA, Houk C, Ahmed SF, et al. Consensus statement on management of intersex disorders. J Pediatr Urol. 2006 Jun;2(3):148–62.PubMedCrossRef
2.
go back to reference Houk CP, Lee PA. Consensus statement on terminology and management: disorders of sex development. Sex Dev. 2008;2(4–5):172–80.PubMedCrossRef Houk CP, Lee PA. Consensus statement on terminology and management: disorders of sex development. Sex Dev. 2008;2(4–5):172–80.PubMedCrossRef
3.
go back to reference Chang HJ, Clark RD, Bachman H. The phenotype of 45,X/46,XY mosaicism: an analysis of 92 prenatally diagnosed cases. Am J Hum Genet. 1990 Jan;46(1):156–67.PubMedPubMedCentral Chang HJ, Clark RD, Bachman H. The phenotype of 45,X/46,XY mosaicism: an analysis of 92 prenatally diagnosed cases. Am J Hum Genet. 1990 Jan;46(1):156–67.PubMedPubMedCentral
4.
go back to reference McGowan-Jordan J, Simons A, Schmid M, editors. An International System for Human Cytogenomic Nomenclature. Basel, Freiburg: Karger; 2016. McGowan-Jordan J, Simons A, Schmid M, editors. An International System for Human Cytogenomic Nomenclature. Basel, Freiburg: Karger; 2016.
5.
go back to reference Hu YM, Jiang ZF. Zhu Fu tang practice of pediatrics. 7th ed. Beijing: People’s Medical Publishing House; 2002. p. 23–38. Hu YM, Jiang ZF. Zhu Fu tang practice of pediatrics. 7th ed. Beijing: People’s Medical Publishing House; 2002. p. 23–38.
8.
go back to reference Ahmed SF, Khwaja O, Hughes IA. The role of a clinical score in the assessment of ambiguous genitalia. BJU Int. 2000 Jan;85(1):120–4.PubMedCrossRef Ahmed SF, Khwaja O, Hughes IA. The role of a clinical score in the assessment of ambiguous genitalia. BJU Int. 2000 Jan;85(1):120–4.PubMedCrossRef
9.
go back to reference Welt CK. Primary ovarian insufficiency: a more accurate term for premature ovarian failure. Clin Endocrinol. 2008 Apr;68(4):499–509.CrossRef Welt CK. Primary ovarian insufficiency: a more accurate term for premature ovarian failure. Clin Endocrinol. 2008 Apr;68(4):499–509.CrossRef
10.
go back to reference Ocal G, Berberoğlu M, Sıklar Z, et al. The clinical and genetic heterogeneity of mixed gonadal dysgenesis: does "disorders of sexualdevelopment (DSD)" classification based on new Chicago consensus cover all sex chromosome DSD? Eur J Pediatr. 2012 Oct;171(10):1497–502.PubMedCrossRef Ocal G, Berberoğlu M, Sıklar Z, et al. The clinical and genetic heterogeneity of mixed gonadal dysgenesis: does "disorders of sexualdevelopment (DSD)" classification based on new Chicago consensus cover all sex chromosome DSD? Eur J Pediatr. 2012 Oct;171(10):1497–502.PubMedCrossRef
11.
go back to reference Slowikowska-Hilczer J, Szarras-Czapnik M, Wolski JK, et al. The risk of neoplasm associated with dysgenetic testes in prepubertal and pubertal/adult patients. Folia Histochem Cytobiol. 2015;53(3):218–26.PubMedCrossRef Slowikowska-Hilczer J, Szarras-Czapnik M, Wolski JK, et al. The risk of neoplasm associated with dysgenetic testes in prepubertal and pubertal/adult patients. Folia Histochem Cytobiol. 2015;53(3):218–26.PubMedCrossRef
12.
go back to reference Moch H, Humphrey PA, Ulbright TM, Reuter VE. WHO classification of Tumours of the urinary system and male genital organs, vol. 8. 4th ed; 2016. Moch H, Humphrey PA, Ulbright TM, Reuter VE. WHO classification of Tumours of the urinary system and male genital organs, vol. 8. 4th ed; 2016.
13.
go back to reference Colindres JV, Axelrad M, McCullough L, et al. Evidence-Based Management of Patients with 45,X/46,XY Gonadal Dysgenesis and Male Sex Assignment: from Infancy to Adulthood. Pediatr Endocrinol Rev. 2016 Mar;13(3):585–601.PubMed Colindres JV, Axelrad M, McCullough L, et al. Evidence-Based Management of Patients with 45,X/46,XY Gonadal Dysgenesis and Male Sex Assignment: from Infancy to Adulthood. Pediatr Endocrinol Rev. 2016 Mar;13(3):585–601.PubMed
14.
go back to reference Robinson WP, Binkert F, Bernasconi F, et al. Molecular studies of chromosomal mosaicism: relative frequency of chromosome gain or loss and possible role of cell selection. Am J Hum Genet. 1995 Feb;56(2):444–51.PubMedPubMedCentral Robinson WP, Binkert F, Bernasconi F, et al. Molecular studies of chromosomal mosaicism: relative frequency of chromosome gain or loss and possible role of cell selection. Am J Hum Genet. 1995 Feb;56(2):444–51.PubMedPubMedCentral
15.
go back to reference Rosa RF, D’Ecclesiis WF, Dibbi RP, et al. 45,X/46,XY mosaicism: report on 14 patients from a Brazilian hospital. A retrospective study. Sao Paulo Med J. 2014 Dec;132(6):332–8.PubMedCrossRef Rosa RF, D’Ecclesiis WF, Dibbi RP, et al. 45,X/46,XY mosaicism: report on 14 patients from a Brazilian hospital. A retrospective study. Sao Paulo Med J. 2014 Dec;132(6):332–8.PubMedCrossRef
16.
go back to reference Telvi L, Lebbar A, Del Pino O, et al. 45,X/46, XY mosaicism: report of 27 cases. Pediatrics. 1999 Aug;104(2 Pt 1):304–8.PubMedCrossRef Telvi L, Lebbar A, Del Pino O, et al. 45,X/46, XY mosaicism: report of 27 cases. Pediatrics. 1999 Aug;104(2 Pt 1):304–8.PubMedCrossRef
17.
go back to reference Tosson H, Rose SR, Gartner LA. Children with 45,X/46,XY karyotype from birth to adult height. Hom Res Paediatr. 2010;74(3):190–200.CrossRef Tosson H, Rose SR, Gartner LA. Children with 45,X/46,XY karyotype from birth to adult height. Hom Res Paediatr. 2010;74(3):190–200.CrossRef
18.
go back to reference Martinerie L, Morel Y, Gay CL, et al. Impaired puberty, fertility, and final stature in45,X/46, XY mixed gonadal dysgenetic patients raised as boys. Eur J Endocrinol. 2012 Apr;166(4):687–94.PubMedCrossRef Martinerie L, Morel Y, Gay CL, et al. Impaired puberty, fertility, and final stature in45,X/46, XY mixed gonadal dysgenetic patients raised as boys. Eur J Endocrinol. 2012 Apr;166(4):687–94.PubMedCrossRef
19.
go back to reference Chen G, Dou J, Yang G, et al. The diagnosis, treatment and following up of 7 patients with 45, X/46,XY mixed gonadal dysgenesis. Zhonghua Nei Ke Za Zhi. 2015;54(11):954–8.PubMed Chen G, Dou J, Yang G, et al. The diagnosis, treatment and following up of 7 patients with 45, X/46,XY mixed gonadal dysgenesis. Zhonghua Nei Ke Za Zhi. 2015;54(11):954–8.PubMed
20.
go back to reference Wu Q, Wang C, Shi H, et al. The clinical manifestation and genetic evaluation in patients with 45,X/46,XY mosaicism. Sex Dev. 2017;11(2):64–9.PubMedCrossRef Wu Q, Wang C, Shi H, et al. The clinical manifestation and genetic evaluation in patients with 45,X/46,XY mosaicism. Sex Dev. 2017;11(2):64–9.PubMedCrossRef
21.
go back to reference Huang YC, Lee CT, Wu MZ, et al. The spectrum of 45,X/46,XY mosaicism in Taiwanese children: the experience of a single center. J Formos Med Assoc. 2019 Jan;118(1 Pt 3):450–6.PubMedCrossRef Huang YC, Lee CT, Wu MZ, et al. The spectrum of 45,X/46,XY mosaicism in Taiwanese children: the experience of a single center. J Formos Med Assoc. 2019 Jan;118(1 Pt 3):450–6.PubMedCrossRef
22.
go back to reference Lindhardt Johansen M, Hagen CP, Rajpert-De Meyts E, et al. 45,X/46,XY mosaicism: phenotypic characteristics, growth, and reproductive function: are trospective longitudinal study. J Clin Endocrinol Metab. 2012 Aug;97(8):E1540–9.PubMedCrossRef Lindhardt Johansen M, Hagen CP, Rajpert-De Meyts E, et al. 45,X/46,XY mosaicism: phenotypic characteristics, growth, and reproductive function: are trospective longitudinal study. J Clin Endocrinol Metab. 2012 Aug;97(8):E1540–9.PubMedCrossRef
23.
go back to reference Patsalis PC, Skordis N, Sismani C, et al. Identification of high frequency of Y chromosome deletions in patients with sex chromosome mosaicism and correlation with the clinical phenotype and Y-chromosome instability. Am J Med Genet A. 2005 Jun 1;135(2):145–9.PubMedCrossRef Patsalis PC, Skordis N, Sismani C, et al. Identification of high frequency of Y chromosome deletions in patients with sex chromosome mosaicism and correlation with the clinical phenotype and Y-chromosome instability. Am J Med Genet A. 2005 Jun 1;135(2):145–9.PubMedCrossRef
24.
go back to reference Kibar Y, Frimberger D, Kropp BP, et al. Accuracy of perinatal diagnosis of 45,X/46,XY mosaicism and electronic consultation of affected parents. J Pediatr Urol. 2009 Aug;5(4):274–8.PubMedCrossRef Kibar Y, Frimberger D, Kropp BP, et al. Accuracy of perinatal diagnosis of 45,X/46,XY mosaicism and electronic consultation of affected parents. J Pediatr Urol. 2009 Aug;5(4):274–8.PubMedCrossRef
25.
go back to reference Farrugia MK, Sebire NJ, Achermann JC, et al. Clinical and gonadal features and early surgical management of 45,X/46,XY and 45,X/47,XYY chromosomal mosaicism presenting with genital anomalies. J Pediatr Urol. 2013;9(2):139–44.PubMedPubMedCentralCrossRef Farrugia MK, Sebire NJ, Achermann JC, et al. Clinical and gonadal features and early surgical management of 45,X/46,XY and 45,X/47,XYY chromosomal mosaicism presenting with genital anomalies. J Pediatr Urol. 2013;9(2):139–44.PubMedPubMedCentralCrossRef
26.
go back to reference Jiang JF, Tian QJ, Xue W, et al. Clinical features of 32 patients with XO/XY gonadal dysgenesis. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2016 Aug;38(4):411–4.PubMed Jiang JF, Tian QJ, Xue W, et al. Clinical features of 32 patients with XO/XY gonadal dysgenesis. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2016 Aug;38(4):411–4.PubMed
27.
go back to reference Tosson H, Rose SR, Gartner LA. Description of children with 45,X/46,XY karyotype. Eur J Pediatr. 2012 Mar;171(3):521–9.PubMedCrossRef Tosson H, Rose SR, Gartner LA. Description of children with 45,X/46,XY karyotype. Eur J Pediatr. 2012 Mar;171(3):521–9.PubMedCrossRef
28.
go back to reference Dendrinos ML, Smorgick N, Marsh CA, et al. Occurrence of Gonadoblastoma in patients with 45,X/46,XY mosaicism. J Pediatr Adolesc Gynecol. 2015 Jun;28(3):192–5.PubMedCrossRef Dendrinos ML, Smorgick N, Marsh CA, et al. Occurrence of Gonadoblastoma in patients with 45,X/46,XY mosaicism. J Pediatr Adolesc Gynecol. 2015 Jun;28(3):192–5.PubMedCrossRef
29.
go back to reference Tam YH, Wong YS, Pang KK, et al. Tumor risk of children with 45,X/46,XY gonadal dysgenesis in relation to their clinical presentations: further insights into the gonadal management. J Pediatr Surg. 2016;51(9):1462–6.PubMedCrossRef Tam YH, Wong YS, Pang KK, et al. Tumor risk of children with 45,X/46,XY gonadal dysgenesis in relation to their clinical presentations: further insights into the gonadal management. J Pediatr Surg. 2016;51(9):1462–6.PubMedCrossRef
30.
go back to reference Mohammadpour Lashkari F, Sadighi Gilani MA, Ghaheri A, et al. Clinical aspects of 49 infertile males with 45,X/46,XY mosaicism karyotype: a case series. Andrologia. 2018 Jun;50(5):e13009.PubMedCrossRef Mohammadpour Lashkari F, Sadighi Gilani MA, Ghaheri A, et al. Clinical aspects of 49 infertile males with 45,X/46,XY mosaicism karyotype: a case series. Andrologia. 2018 Jun;50(5):e13009.PubMedCrossRef
31.
go back to reference Cools M, Pleskacova J, Stoop H, et al. Gonadal pathology and tumor risk in relation to clinical characteristics in patients with 45,X/46,XY mosaicism. J Clin Endocrinol Metab. 2011 Jul;96(7):E1171–80.PubMedCrossRef Cools M, Pleskacova J, Stoop H, et al. Gonadal pathology and tumor risk in relation to clinical characteristics in patients with 45,X/46,XY mosaicism. J Clin Endocrinol Metab. 2011 Jul;96(7):E1171–80.PubMedCrossRef
32.
go back to reference Kersemaekers AM, Honecke F, Stoop M, et al. Identification of germ cells at risk for neoplastic transformation in gonadoblastoma: an immunohistochemical study for OCT3/4 and TSPY. Hum Pathol. 2005 May;36(5):512–21.PubMedCrossRef Kersemaekers AM, Honecke F, Stoop M, et al. Identification of germ cells at risk for neoplastic transformation in gonadoblastoma: an immunohistochemical study for OCT3/4 and TSPY. Hum Pathol. 2005 May;36(5):512–21.PubMedCrossRef
33.
go back to reference Palma I, Garibay N, Pena-Yolanda R, et al. Utility of OCT3/4,TSPY and β-catenin as biological markers for gonadoblastoma formation and malignant germ cell tumor development in dysgenetic gonads. Dis Markers. 2013;34:419–24.PubMedPubMedCentralCrossRef Palma I, Garibay N, Pena-Yolanda R, et al. Utility of OCT3/4,TSPY and β-catenin as biological markers for gonadoblastoma formation and malignant germ cell tumor development in dysgenetic gonads. Dis Markers. 2013;34:419–24.PubMedPubMedCentralCrossRef
34.
go back to reference Oosterhuis JW, Stoop H, Dohle G, et al. A pathologist’s view on the testis biopsy. Int J Androl. 2011 Aug;34(4 Pt 2):e14–9.PubMedCrossRef Oosterhuis JW, Stoop H, Dohle G, et al. A pathologist’s view on the testis biopsy. Int J Androl. 2011 Aug;34(4 Pt 2):e14–9.PubMedCrossRef
35.
go back to reference Thorup J, Clasen-Linde E, Cortes D. Positive Oct-3/4 and D2-40 Immunohistochemical expression in germ cells and suspected histology pattern of IntratubularGerm cell neoplasia in boys with cryptorchidism vanish after the age of 2 years. Eur J Pediatr Surg. 2017 Aug;27(4):313–8.PubMedCrossRef Thorup J, Clasen-Linde E, Cortes D. Positive Oct-3/4 and D2-40 Immunohistochemical expression in germ cells and suspected histology pattern of IntratubularGerm cell neoplasia in boys with cryptorchidism vanish after the age of 2 years. Eur J Pediatr Surg. 2017 Aug;27(4):313–8.PubMedCrossRef
Metadata
Title
Growth data and tumour risk of 32 Chinese children and adolescents with 45,X/46,XY mosaicism
Authors
Lili Pan
Zhe Su
Jianming Song
Wanhua Xu
Xia Liu
Longjiang Zhang
Shoulin Li
on behalf of the multidisciplinary collaboration team of DSD management at Shenzhen Children’s Hospital
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Pediatrics / Issue 1/2019
Electronic ISSN: 1471-2431
DOI
https://doi.org/10.1186/s12887-019-1520-9

Other articles of this Issue 1/2019

BMC Pediatrics 1/2019 Go to the issue